Probiotic supplement for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether taking a probiotic supplement (a product with helpful bacteria) can improve blood sugar control and gut health in people with type 1 diabetes. It involves taking the supplement, providing stool and blood samples, and attending follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have type 1 diabetes for at least 1 year (this study is for people with diabetes, not healthy controls).
- You must not have taken antibiotics, probiotics, or prebiotics in the 4 weeks before the study starts.
- You must not have any chronic gut diseases like Crohn's disease or irritable bowel syndrome.
- You must not be pregnant, breastfeeding, or have a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called LP-LDL® to see if it improves blood sugar, cholesterol, and thinking in people with prediabetes or diabetes. It may help you manage your condition better.
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
This study tests if taking inulin, a type of fiber, can help improve blood sugar control and immune health in people with type 1 diabetes. Participants will take a daily supplement for a period of time to see if it makes a difference.
This trial studies whether taking prebiotics can change gut bacteria (gut microbiome) in people with type 1 diabetes. The goal is to see if these gut changes are linked to better health or diabetes-related outcomes.
This study looks at children who have just started insulin for new-onset type 1 diabetes. It aims to test an intervention early in the course of the disease, which may help change how the immune system and diabetes progress.
This study tests whether a specific beneficial bacteria supplement (called Lactobacillus paracasei LC19) can help control blood sugar in people with newly diagnosed type 2 diabetes. It may offer an option to manage diabetes without starting medication right away.
Hear when a new Diabete Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.